GLUCAGEN FOR INJECTION 1mg/ML

Product Information

Registration Status: Active

GLUCAGEN FOR INJECTION 1mg/ML is approved to be sold in Singapore with effective from 1996-09-12. It is marketed by NOVO NORDISK PHARMA (SINGAPORE) PTE LTD, with the registration number of SIN09070P.

This product contains Glucagon 1mg/ml in the form of INJECTION, POWDER, FOR SOLUTION. It is approved for INTRAVENOUS, SUBCUTANEOUS, INTRAMUSCULAR use.

This product is manufactured by Novo Nordisk A/S in DENMARK.

It is a Prescription Only Medicine that can only be obtained from a doctor or a dentist, or a pharmacist with a prescription from a Singapore-registered doctor or dentist.

Glucagon

Description

29 residue peptide hormone. Glucagon is synthesized in a special non- pathogenic laboratory strain of Escherichia coli bacteria that has been genetically altered by the addition of the gene for glucagons

Indication

For treatment of severe hypoglycemia, also used in gastrointestinal imaging

Mechanism of Action

Glucagon binds the glucagon receptor, a G protein-coupled receptor located in the plasma membrane, which then initiates a dual signaling pathway using both adenylate cyclase activation and increased intracellular calcium. Adenylate cyclase manufactures cAMP (cyclic AMP), which activates protein kinase A (cAMP-dependent protein kinase). This enzyme, in turn, activates phosphorylase kinase, which, in turn, phosphorylates glycogen phosphorylase, converting into the active form called phosphorylase A. Phosphorylase A is the enzyme responsible for the release of glucose-1-phosphate from glycogen polymers. This yields glucose molecules to be released into the blood. Glucagon receptors are found in the liver, kidney, brain and pancreatic islet cells. The glucagon mediated signals lead to an increase in insulin excretion

Clearance

* 13.5  mL/min/kg [Adults with IV 1 mg]

Active Ingredient/Synonyms

Glucagon | Glucagon (recombinant dna origin) | Glucagon, human | Glucagon, porcine | Glucagone | Glucagonum | Glucagon recombinant |


Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.

References

  1. Health Science Authority of Singapore - Reclassified POM
  2. Drugbank